Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Neoplasms of the CNS

Free Subscription 20.05.2024 2 Acta Neuropathol 1 Br J Neurosurg 1 Cancer 2 Childs Nerv Syst 1 Clin Cancer Res 4 Int J Radiat Oncol Biol Phys 17 J Neurooncol 1 J Neurosurg 2 Nat Rev Neurol 2 Neuro Oncol 1 Neurology 1 PLoS One 1 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. SCHULLER U, Gocke A, Godbole S, Delbridge C, et al
   Anaplastic histology and distinct molecular features in a small series of spinal cord ependymomas.
   Acta Neuropathol. 2024;147:83.
   PubMed        
   
   
2. LIN AL, Rudneva VA, Richards AL, Zhang Y, et al
   Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
   Acta Neuropathol. 2024;147:85.
   PubMed         Abstract available
   
   

   
   Br J Neurosurg

3. KUMARIA A, Leggate AJ, Dow GR, Ingale HA, et al
   A common tumour in a rare location: a single centre case series of cerebellar glioblastoma.
   Br J Neurosurg. 2024 May 14:1-6. doi: 10.1080/02688697.2024.2348598.
   PubMed         Abstract available
   
   

   
   Cancer

4. HSIEH AL, Bi WL, Ramesh V, Brastianos PK, et al
   Evolving concepts in meningioma management in the era of genomics.
   Cancer. 2024 May 16. doi: 10.1002/cncr.35279.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

5. KROUMA M, Soilihi AA, Pech-Gourg G, Arnaud S, et al
   Correction: Takotsubo syndrome linked to paroxysmal sympathetic hyperactivity as a postoperative complication after brain tumor removal: a case report and literature review.
   Childs Nerv Syst. 2024 May 16. doi: 10.1007/s00381-024-06418.
   PubMed        
   
   
6. KIM JW, Kim SK
   The role of surgery for optic pathway gliomas in the era of precision medicine.
   Childs Nerv Syst. 2024 May 14. doi: 10.1007/s00381-024-06450.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

7. JAIN S, Griffith JI, Porath KA, Rathi S, et al
   Bystander effects, pharmacokinetics, and linker-payload stability of EGFR-targeting antibody-drug conjugates Losatuxizumab vedotin and Depatux-M in glioblastoma models.
   Clin Cancer Res. 2024 May 14. doi: 10.1158/1078-0432.CCR-24-0426.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

8. MAHAJAN A, Stavinoha PL, Rongthong W, Brodin NP, et al
   Neurocognitive Effects and Necrosis in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.
   Int J Radiat Oncol Biol Phys. 2024;119:401-416.
   PubMed         Abstract available
   
   
9. WAXER JF, Wong K, Modiri A, Charpentier AM, et al
   Risk of Cerebrovascular Events Among Childhood and Adolescent Patients Receiving Cranial Radiation Therapy: A PENTEC Normal Tissue Outcomes Comprehensive Review.
   Int J Radiat Oncol Biol Phys. 2024;119:417-430.
   PubMed         Abstract available
   
   
10. CASEY DL, Vogelius IR, Brodin NP, Roberts KB, et al
    Risk of Subsequent Neoplasms in Childhood Cancer Survivors After Radiation Therapy: A PENTEC Comprehensive Review.
    Int J Radiat Oncol Biol Phys. 2024;119:640-654.
    PubMed         Abstract available
    
    
11. AJITHKUMAR T, Avanzo M, Yorke E, Tsang DS, et al
    Brain and Brain Stem Necrosis After Reirradiation for Recurrent Childhood Primary Central Nervous System Tumors: A PENTEC Comprehensive Review.
    Int J Radiat Oncol Biol Phys. 2024;119:655-668.
    PubMed         Abstract available
    
    

    
    J Neurooncol

12. NAKAGAWA K, Takano K, Nishino K, Ohe S, et al
    Prognostic impact of clinical and radiological factors on leptomeningeal metastasis from solid cancers.
    J Neurooncol. 2024;167:397-406.
    PubMed         Abstract available
    
    
13. DAVISON MA, Lilly DT, Patel AA, Kashkoush A, et al
    Clinical presentation and extent of resection impacts progression-free survival in spinal ependymomas.
    J Neurooncol. 2024;167:437-446.
    PubMed         Abstract available
    
    
14. TONG T, Chen H, Mo C, Zhong L, et al
    Clinical characteristics and predictive factors of delayed diagnosis in patients with sellar germ cell tumors.
    J Neurooncol. 2024;167:467-476.
    PubMed         Abstract available
    
    
15. BARBOUR AB, Blouw B, Taylor LP, Graber JJ, et al
    Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumors.
    J Neurooncol. 2024;167:509-514.
    PubMed         Abstract available
    
    
16. LALANCETTE E, Cantin E, Routhier ME, Mailloux C, et al
    Impact of trametinib on the neuropsychological profile of NF1 patients.
    J Neurooncol. 2024;167:447-454.
    PubMed         Abstract available
    
    
17. KASATKIN VN, Romanova EN, Glebova EV, Deviaterikova AA, et al
    Effects of cognitive-motor intervention for pediatric posterior fossa tumor survivors: results of a pilot study.
    J Neurooncol. 2024;168:57-67.
    PubMed         Abstract available
    
    
18. WANG M, Chen M, Ge Y
    Comment on "Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control''.
    J Neurooncol. 2024;167:525.
    PubMed        
    
    
19. RODRIGUES AJ, Chernikova SB, Wang Y, Trinh TTH, et al
    Repurposing mebendazole against triple-negative breast cancer CNS metastasis.
    J Neurooncol. 2024;168:125-138.
    PubMed         Abstract available
    
    
20. ABDULSALAM AJ, Kara M, Ozcakar L
    Elevating the findings by substituting in "ISarcoPRM".
    J Neurooncol. 2024;168:185-186.
    PubMed        
    
    
21. FEHRENBACH MK, Wilhelmy F, Wende T, Guresir E, et al
    Perioperative psychological distress in patients with intracranial tumors; a single center study.
    J Neurooncol. 2024;168:151-157.
    PubMed         Abstract available
    
    
22. GECICI NN, Gurses ME, Kaye B, Jimenez NLF, et al
    Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis.
    J Neurooncol. 2024;168:1-11.
    PubMed         Abstract available
    
    
23. POLETES C, Amanirad B, Santiago AT, Yan M, et al
    The incidence of brain metastases in breast cancer according to molecular subtype and stage: a 10-year single institution analysis.
    J Neurooncol. 2024 May 13. doi: 10.1007/s11060-024-04707.
    PubMed         Abstract available
    
    
24. RALEIGH DR, Chen WC, Gondi V, Rogers L, et al
    Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice.
    J Neurooncol. 2024 May 14. doi: 10.1007/s11060-024-04700.
    PubMed        
    
    
25. GOULENKO V, Madhugiri VS, Bregy A, Recker M, et al
    Histopathological correlation of brain tumor recurrence vs. radiation effect post-radiosurgery as detected by MRI contrast clearance analysis: a validation study.
    J Neurooncol. 2024 May 15. doi: 10.1007/s11060-024-04697.
    PubMed         Abstract available
    
    
26. PECIU-FLORIANU I, Vannod-Michel Q, Vauleon E, Bonneterre ME, et al
    Long term follow-up of patients with newly diagnosed glioblastoma treated by intraoperative photodynamic therapy: an update from the INDYGO trial (NCT03048240).
    J Neurooncol. 2024 May 16. doi: 10.1007/s11060-024-04693.
    PubMed         Abstract available
    
    
27. RONSLEY R, Karvonen KA, Cole B, Paulson V, et al
    Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors.
    J Neurooncol. 2024 May 16. doi: 10.1007/s11060-024-04645.
    PubMed         Abstract available
    
    
28. DORON O, Wong T, Ablyazova F, Singha S, et al
    Correction to: Results from a first-in-human phase I safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma.
    J Neurooncol. 2024 May 17. doi: 10.1007/s11060-024-04701.
    PubMed        
    
    

    
    J Neurosurg

29. ALBANO L, Losa M, Barzaghi LR, Mortini P, et al
    Letter to the Editor. Management of residual nonfunctioning pituitary adenoma: watchful waiting or adjuvant treatment?
    J Neurosurg. 2023;138:1782-1784.
    PubMed        
    
    

    
    Nat Rev Neurol

30. FYFE I
    CAR T cells offer hope in glioblastoma.
    Nat Rev Neurol. 2024 May 14. doi: 10.1038/s41582-024-00972.
    PubMed        
    
    
31. RUDA R, Horbinski C, van den Bent M, Preusser M, et al
    IDH inhibition in gliomas: from preclinical models to clinical trials.
    Nat Rev Neurol. 2024 May 17. doi: 10.1038/s41582-024-00967.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

32. O'HARE P, Cooney T, de Blank P, Gutmann DH, et al
    Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma Coalition.
    Neuro Oncol. 2024 May 14:noae074. doi: 10.1093.
    PubMed         Abstract available
    
    
33. LEON BE, Bayik D
    A triad between sex, necrosis, and inflammation shapes glioblastoma outcomes.
    Neuro Oncol. 2024 May 14:noae086. doi: 10.1093.
    PubMed        
    
    

    
    Neurology

34. VIDAL I, Antunes AP, Morgado C, Simas N, et al
    Pearls & Oy-sters: A Challenging Optic Neuropathy-What Not to Miss in Optic Nerve Sheath Enhancement.
    Neurology. 2024;102:e209494.
    PubMed         Abstract available
    
    

    
    PLoS One

35. AUNG TM, Ngamjarus C, Proungvitaya T, Saengboonmee C, et al
    Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0303337.
    PubMed         Abstract available
    
    

    
    Radiology

36. JI Q, McAfee SS, Scoggins M, Holtrop J, et al
    Cerebellar Mutism Syndrome and Dentato-Thalamo-Cortical Tract Disruption in Diffusion Tractography Following Surgery for Medulloblastoma.
    Radiology. 2024;311:e232521.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.